Rep. Frank Pallone, Jr., is seeking information from six IDR entities amid concerns about No Surprises Act arbitration ...

Flare Capital Partners led the Series A round. Craft, Obvious Ventures, Eniac Ventures, InHealth Ventures, Epsilon Health ...

Forus' $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst ...

Nutromics earned FDA breakthrough device designation for its wearable patch that tracks vancomycin levels in real time. The ...

The 2026 Healthcare AI Readiness Index, a new report by Cotiviti and MedCity News, is based on a survey of 70 healthcare leaders over the summer and shares candid views of how they balance harnessing ...

A PHTI analysis found that virtual CKD management programs have little impact on disease progression or healthcare spending ...

A Georgetown report outlines three strategies to improve health insurance by lowering costs, simplifying coverage and protecting patients from corporate abuses.

GSK gained rights to a Hutchmed antibody-targeted therapy conjugate, or ATTC. This new type of targeted therapy blocks two cancer-driving proteins and will initially be developed for lung, colorectal, ...

LEP Biomedical is developing a dissolvable implant that replaces weeks of self-administered eye drops after glaucoma surgery, ...

Early intervention based on accurate diagnosis of both metabolic risk factors and acute cardiac events could help make the ...